Merry Christmas to all pros!
They Did It. FDA Bans Breast Cancer Drug Avastin by Tammy Bruce on Wednesday, December 22, 2010 at 6:21pm
All the cowards wait until the end of December. ObamaCare rationing begins. Ironically, the FDA’s banning of Avastin happens on the same day it’s European counterpart officially approved its use. Make no mistake, this decision was one about cost for those who are terminally ill and fighting for another chance, or another 6 months. Remember–when people are the budget…
I believe the new Congress can walk and chew gum at the same time. There are many things they need to do, but at the very top of the list must be the complete repeal of the evil obscenity of ObamaCare. (HT to @gerfingerpoken at Twitter). Please read the entire IBD editorial, below is just a snippet. BTW, if you can read only one paper a day it should be Investors Business Daily. Their news reporting and editorial content is singularly fabulous.
IBD: ObamaCare Rationing Begins
The FDA has reversed its approval of a widely used cancer drug approved in Europe to treat breast cancer on the grounds it doesn’t provide a “sufficient” benefit. Let the terminally ill and their doctors decide.
One of the blessings of blocking the omnibus spending bill was that it included $1 billion for the implementation of ObamaCare.
Yet the first effects are still being felt, the latest being the Food and Drug Administration’s revoking of regulatory approval of Avastin to treat late-stage breast cancer.
The reason given by the FDA was that the drug does not provide “a sufficient benefit in slowing disease progression to outweigh the significant risk to patients.” What risk? These women are dying.
The drug buys them precious time, and the only risk they face is from an FDA saying “pull the plug.”
On the same day the FDA channeled Dr. Kevorkian, its European counterpart, the European Medicines Agency, issued a statement approving Avastin for metastatic breast cancer…
Share and Enjoy: |
